tirzepatide and estrogen Postmenopausal women on the GLP-1 medication (Zepbound) for obesity lost more weight if they were also using menopause hormone therapy, a retrospective cohort study indicated. https://www.medpagetoday.com/endocrinology/menopause/119594 Tirzepatide caused roughly half as

Unless specifically prescribed, most patients will be on a once-weekly injection schedule with medications like semaglutide or tirzepatide

Additionally, many people are stigmatized because of their weight, the CDC noted

IL-1, IL-10, eotaxin-1, leptin, and TNF- concentrations were examined in blood, while total glutathione (GSHt), reduced glutathione (GSH), oxidized glutathione (GSSG) and SH groups were measured in lung homogenates

The information that matters: Medication name (Zepbound, Wegovy, Mounjaro, compounded tirzepatide, compounded semaglutide) Dose in mg (not just "the highest one" or "the lowest one") Date of last injection How long you've been on this dose Any GI side effects you've had (nausea, vomiting, reflux, constipation) Other relevant medications (diabetes medications especially) Don't assume they've already pulled this from your medical record